18F-FDG PET/CT Guided Reduced-dose Radiotherapy for Nasopharyngeal Carcinoma
ConditionNasopharyngeal Carcinoma
Trial statusRecruiting
Trial phasePhase 2
Trial typeInterventional
Biological sexAll
Age18-80
SponsorTaizhou Hospital
About this trial
The purpose of this study is to explore whether 18F-FDG PET/CT guided reduced-dose radiotherapy would maintain survival outcomes in nasopharyngeal carcinoma (NPC) patients.
Eligibility criteria
Qualifiers
Pathology confirmed nasopharyngeal squamous cell carcinoma.
Stage I-IVA（8thAJCC/UICC staging system).
Aged 18-80 years.
KPS≥70.
Disqualifiers
Past malignancies history (except for stage I non-melanoma skin cancer or cervical carcinoma in situ).
Age <18 or >80years.
Pregnancy or lactation.
History of previous radiotherapy (except for non-melanomatous skin cancers outside intended RT treatment volume).
Trial design
Treatments tested in this trial
- Reduced dose
- Conventional dose
- Chemotherapy
Treatment groups
93 Participants
are divided into 2 treatment groupsSponsors and collaborators
Taizhou Hospital
Lead sponsor
Taizhou Enze Medical Center Group
Collaborator
Taizhou Cancer Hospital
Collaborator
Source ClinicalTrials.gov